As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

Everything from AI-generated videos of celebrities to fake online pharmacies are being used to try to dupe consumers ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidenceSAN FRANCISCO, Jan. 08, 2026 ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...

State health plan overseers are pushing back against potential plan design changes that would shift more costs onto enrollees, particularly a staff recommendation to help close a large budget gap by ...

A large review found that people who stopped taking GLP-1 drugs regained weight nearly twice as fast as people who gave up ...

When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

Losing 1 pound of weight can be a numbers game. You need to cut your caloric intake while increasing the number of calories you burn through physical activity.